These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4436146)

  • 1. Microbial conversion of antibiotics. IV. Reduction of maridomycin.
    Nakahama K; Igarasi S
    J Antibiot (Tokyo); 1974 Aug; 27(8):605-9. PubMed ID: 4436146
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial conversion of antibiotics. 3. Hydroxylation of maridomycin I and josamycin.
    Nakahama K; Kishi T; Igarasi S
    J Antibiot (Tokyo); 1974 Jun; 27(6):433-41. PubMed ID: 4853208
    [No Abstract]   [Full Text] [Related]  

  • 3. A42867, a novel glycopeptide antibiotic.
    Riva E; Gastaldo L; Beretta MG; Ferrari P; Zerilli LF; Cassani G; Selva E; Goldstein BP; Berti M; Parenti F
    J Antibiot (Tokyo); 1989 Apr; 42(4):497-505. PubMed ID: 2722670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics produced by mutants of Streptomyces caelestis. I. 7-O-demethylcelesticetin and its degradation products.
    Argoudelis AD; Coats JH; Lemaux PG; Sebek OK
    J Antibiot (Tokyo); 1972 Aug; 25(8):445-55. PubMed ID: 4648486
    [No Abstract]   [Full Text] [Related]  

  • 5. Tubelactomicin A, a novel 16-membered lactone antibiotic, from Nocardia sp. I. Taxonomy, production, isolation and biological properties.
    Igarashi M; Hayashi C; Homma Y; Hattori S; Kinoshita N; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 2000 Oct; 53(10):1096-101. PubMed ID: 11132953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on a new amino acid antibiotic, amiclenomycin.
    Okami Y; Kitahara T; Hamada M; Naganawa H; Kondo S
    J Antibiot (Tokyo); 1974 Sep; 27(9):656-64. PubMed ID: 4436150
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation of fusidic acid by pathogenic Nocardia.
    Harada K; Tomita K; Fujii K; Sato N; Uchida H; Yazawa K; Mikami Y
    J Antibiot (Tokyo); 1999 Mar; 52(3):335-9. PubMed ID: 10348053
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Microbial conversion of antibiotics. II. Deacylation of maridomycin by Actinomycetes.
    Nakahama K; Kishi T; Igarasi S
    J Antibiot (Tokyo); 1974 Jun; 27(6):487-8. PubMed ID: 4852860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiotics of an aromatic nature from Pseudomonas cepacia].
    Smirnov VV; Kiprianova EA; Dodatko TA; Garagulia AD; Kliuev NA
    Mikrobiol Zh (1978); 1991; 53(5):41-5. PubMed ID: 1724281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isodeoxyhelicobasidin, a novel human neutrophil elastase inhibitor from the culture broth of Volvariella bombycina.
    Xu GH; Kim YH; Choo SJ; Ryoo IJ; Zheng CJ; Seok SJ; Kim WG; Yoo ID
    J Antibiot (Tokyo); 2009 Jun; 62(6):333-4. PubMed ID: 19329988
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation, characterization and structures of PA-46101 A and B.
    Matsumoto M; Kawamura Y; Yoshimura Y; Terui Y; Nakai H; Yoshida T; Shoji J
    J Antibiot (Tokyo); 1990 Jul; 43(7):739-47. PubMed ID: 2387767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascochytatin, a novel bioactive spirodioxynaphthalene metabolite produced by the marine-derived fungus, Ascochyta sp. NGB4.
    Kanoh K; Okada A; Adachi K; Imagawa H; Nishizawa M; Matsuda S; Shizuri Y; Utsumi R
    J Antibiot (Tokyo); 2008 Mar; 61(3):142-8. PubMed ID: 18503192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial modification of diosgenin and hecogenin.
    Howe R; Moore RH; Rao BS; Gibson DT
    J Chem Soc Perkin 1; 1973; 17():1940-3. PubMed ID: 4799179
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties.
    Omura S; Imamura N; Oiwa R; Kuga H; Iwata R; Masuma R; Iwai Y
    J Antibiot (Tokyo); 1986 Oct; 39(10):1407-12. PubMed ID: 3781911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the biosynthesis of the erythromycins. 3. Isolation and structure of 5-deoxy-5-oxoerythronolide B, a shunt metabolite of erythromycin biosynthesis.
    Martin JR; Perun TJ
    Biochemistry; 1968 May; 7(5):1728-33. PubMed ID: 4297053
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyathin, a new antibiotic complex produced by Cyathus helenae.
    Allbutt AD; Ayer WA; Brodie HJ; Johri BN; Taube H
    Can J Microbiol; 1971 Nov; 17(11):1401-7. PubMed ID: 5156938
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycinamicins, new macrolide antibiotics. XIII. Isolation and structures of novel fermentation products from Micromonospora griseorubida (FERM BP-705).
    Kinoshita K; Takenaka S; Suzuki H; Morohoshi T; Hayashi M
    J Antibiot (Tokyo); 1992 Jan; 45(1):1-9. PubMed ID: 1548179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of 5,6-dihydrobenzo-[a]-carbazoles. Part II.
    Segall A; Pappa H; Pizzorno MT; Radice M; Amoroso A; Gutkind GO
    Farmaco; 1996 Jul; 51(7):513-6. PubMed ID: 8765674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance towards aminoglycoside-aminocyclitol antibiotics in bacteria.
    Courvalin P; Carlier C
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():57-69. PubMed ID: 7263566
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of bacteria to the newer aminoglycoside antibiotics: an epidemiological and enzymatic study.
    Devaud M; Kayser FH; Huber U
    J Antibiot (Tokyo); 1977 Aug; 30(8):655-64. PubMed ID: 908664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.